Resultados de la búsqueda 21-30 of 10743 for Monoclonal Antibodies

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer ... Monoclonal B Cell Lymphocytosis (MBL) and B-Chronic Lymphocytic Leukemia ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...